5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          High blood urea nitrogen (BUN) is observed in a subset of patients with acute exacerbation of COPD (AECOPD) and may be linked to clinical outcome, but findings from previous studies have been inconsistent.

          Methods

          We performed a retrospective analysis of patients prospectively enrolled in the MAGNET AECOPD Registry study (ChiCTR2100044625). Receiver operating characteristic (ROC) was used to determine the level of BUN that discriminated survivors and non-survivors. Univariate and multivariate Cox proportional hazards regression analyses were performed to assess the impact of BUN on adverse outcomes.

          Results

          Overall, 13,431 consecutive inpatients with AECOPD were included in this study, of whom 173 died, with the mortality of 1.29%. The non-survivors had higher levels of BUN compared with the survivors [9.5 (6.8–15.3) vs 5.6 (4.3–7.5) mmol/L, P < 0.001]. ROC curve analysis showed that the optimal cutoff of BUN level was 7.30 mmol/L for in-hospital mortality (AUC: 0.782; 95% CI: 0.748–0.816; P < 0.001). After multivariate analysis, BUN level ≥7.3 mmol/L was an independent risk factor for in-hospital mortality (HR = 2.099; 95% CI: 1.378–3.197, P = 0.001), also for invasive mechanical ventilation (HR = 1.540; 95% CI: 1.199–1.977, P = 0.001) and intensive care unit admission (HR = 1.344; 95% CI: 1.117–1.617, P = 0.002). Other independent prognostic factors for in-hospital mortality including age, renal dysfunction, heart failure, diastolic blood pressure, pulse rate, PaCO2 and D-dimer.

          Conclusion

          BUN is an independent risk factor for in-hospital mortality in inpatients with AECOPD and may be used to identify serious (or severe) patients and guide the management of AECOPD.

          Clinical Trial Registration

          MAGNET AECOPD; Chinese Clinical Trail Registry NO.: ChiCTR2100044625; Registered March 2021, URL: http://www.chictr.org.cn/showproj.aspx?proj=121626 .

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

          American Journal of Respiratory and Critical Care Medicine, 195(5), 557-582
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

            Although exposure to cigarette smoking and air pollution is common, the current prevalence of chronic obstructive pulmonary disease (COPD) is unknown in the Chinese adult population. We conducted the China Pulmonary Health (CPH) study to assess the prevalence and risk factors of COPD in China.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study.

              W S Lim (2003)
              In the assessment of severity in community acquired pneumonia (CAP), the modified British Thoracic Society (mBTS) rule identifies patients with severe pneumonia but not patients who might be suitable for home management. A multicentre study was conducted to derive and validate a practical severity assessment model for stratifying adults hospitalised with CAP into different management groups. Data from three prospective studies of CAP conducted in the UK, New Zealand, and the Netherlands were combined. A derivation cohort comprising 80% of the data was used to develop the model. Prognostic variables were identified using multiple logistic regression with 30 day mortality as the outcome measure. The final model was tested against the validation cohort. 1068 patients were studied (mean age 64 years, 51.5% male, 30 day mortality 9%). Age >/=65 years (OR 3.5, 95% CI 1.6 to 8.0) and albumin 7 mmol/l, Respiratory rate >/=30/min, low systolic( /=65 years (CURB-65 score) based on information available at initial hospital assessment, enabled patients to be stratified according to increasing risk of mortality: score 0, 0.7%; score 1, 3.2%; score 2, 3%; score 3, 17%; score 4, 41.5% and score 5, 57%. The validation cohort confirmed a similar pattern. A simple six point score based on confusion, urea, respiratory rate, blood pressure, and age can be used to stratify patients with CAP into different management groups.
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                13 July 2023
                2023
                : 18
                : 1445-1455
                Affiliations
                [1 ]Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University , Chengdu, Sichuan Province, People’s Republic of China
                [2 ]State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University , Chengdu, People’s Republic of China
                [3 ]West China School of Medicine, West China Hospital, Sichuan University , Chengdu, Sichuan Province, People’s Republic of China
                [4 ]State Key Laboratory of Respiratory Disease, Guangzhou Medical University , Guangzhou, Guangdong Province, People’s Republic of China
                [5 ]Department of Respiratory and Critical Care Medicine, People’s Hospital of Leshan , Leshan, Sichuan Province, People’s Republic of China
                [6 ]Department of Respiratory and Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou, Zhejiang Province, People’s Republic of China
                [7 ]Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei Province, People’s Republic of China
                [8 ]Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei Province, People’s Republic of China
                [9 ]Department of Respiratory and Critical Care Medicine, The First People’s Hospital of Neijiang City , Neijiang, Sichuan Province, People’s Republic of China
                [10 ]Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University , Changsha, Hunan Province, People’s Republic of China
                [11 ]Department of Emergency, First People’s Hospital of Jiujiang , Jiujiang, Jiangxi Province, People’s Republic of China
                [12 ]Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Chengdu University , Chengdu, Sichuan Province, People’s Republic of China
                [13 ]Sichuan Cancer Hospital, University of Electronic Science and Technology of China , Chengdu, Sichuan Province, People’s Republic of China
                Author notes
                Correspondence: Haixia Zhou; Qun Yi, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University , Guo-Xue-Xiang 37#, Wuhou District, Chengdu, Sichuan Province, 610041, People’s Republic of China, Tel/Fax +86-28-85422571, Email zhouhaixia@wchscu.cn; yiqun925@126.com
                [*]

                These authors contributed equally to this work

                Author information
                http://orcid.org/0000-0003-3324-053X
                http://orcid.org/0000-0002-3302-9139
                http://orcid.org/0000-0002-5205-4487
                Article
                412106
                10.2147/COPD.S412106
                10351588
                37465819
                7b8cfba6-a339-4e04-b566-3d2d58d9cc1f
                © 2023 Zhang et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 11 March 2023
                : 09 July 2023
                Page count
                Figures: 3, Tables: 8, References: 37, Pages: 11
                Funding
                Funded by: the National Natural Science Foundation of China;
                Funded by: the Sichuan Science and Technology Program;
                Funded by: the National Key Research Program of China;
                This study was supported by the National Natural Science Foundation of China (82170013), the Sichuan Science and Technology Program (2022YFS0262) and the National Key Research Program of China (2016YFC1304202).
                Categories
                Original Research

                Respiratory medicine
                aecopd,inpatients,blood urea nitrogen,mortality,adverse outcomes
                Respiratory medicine
                aecopd, inpatients, blood urea nitrogen, mortality, adverse outcomes

                Comments

                Comment on this article